Floatz logo

Odetiglucan

Progressive Colorectal Carcinoma

HiberCell, Inc.other_biologicalPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Progressive Colorectal Carcinoma cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Odetiglucan is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
57 / 100
View asset →
indolent B-cell non-Hodgkin lymphomaDormant
B
Indicative ·
57 / 100
View asset →
triple-negative breast carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →